{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:31:27Z","timestamp":1761060687877},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T00:00:00Z","timestamp":1540339200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1245\/s10434-018-6925-4","type":"journal-article","created":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T19:11:34Z","timestamp":1540408294000},"page":"628-634","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Increased SOX9 Expression in Premalignant and Malignant Pancreatic Neoplasms"],"prefix":"10.1245","volume":"26","author":[{"given":"Jennifer L.","family":"Gnerlich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianzhong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cara","family":"Joyce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher D.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard J.","family":"Abood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel G.","family":"Pappas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard V.","family":"Aranha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,24]]},"reference":[{"issue":"5","key":"6925_CR1","doi-asserted-by":"publisher","first-page":"448","DOI":"10.2174\/187152011795677436","volume":"11","author":"HG Hotz","year":"2011","unstructured":"Hotz HG, Hotz B, Buhr HJ. Genes associated with epithelial-mesenchymal transition: possible therapeutic targets in ductal pancreatic adenocarcinoma? Anticancer Agents Med Chem. 2011;11(5):448\u201354.","journal-title":"Anticancer Agents Med Chem."},{"issue":"1","key":"6925_CR2","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/MPA.0b013e3181878b7f","volume":"38","author":"JM Cates","year":"2009","unstructured":"Cates JM, Byrd RH, Fohn LE, et al. Epithelial-mesenchymal transition markers in pancreatic ductal adenocarcinoma. Pancreas. 2009;38(1):e1\u20136.","journal-title":"Pancreas."},{"issue":"Suppl 4","key":"6925_CR3","doi-asserted-by":"publisher","first-page":"S750","DOI":"10.1245\/s10434-014-3946-5","volume":"21","author":"G Lahat","year":"2014","unstructured":"Lahat G, Lubezky N, Loewenstein S, et al. Epithelial-to-mesenchymal transition (EMT) in intraductal papillary mucinous neoplasm (IPMN) is associated with high tumor grade and adverse outcomes. Ann Surg Oncol. 2014; 21 Suppl 4:S750\u20137.","journal-title":"Ann Surg Oncol."},{"key":"6925_CR4","doi-asserted-by":"publisher","first-page":"7677","DOI":"10.1038\/ncomms8677","volume":"6","author":"R Russell","year":"2015","unstructured":"Russell R, Perkhofer L, Liebau S, et al. Loss of ATM accelerates pancreatic cancer formation and epithelial-mesenchymal transition. Nat Commun. 2015;6:7677.","journal-title":"Nat Commun."},{"key":"6925_CR5","first-page":"1261","volume":"6","author":"JA Castellanos","year":"2013","unstructured":"Castellanos JA, Merchant NB, Nagathihalli NS. Emerging targets in pancreatic cancer: epithelial-mesenchymal transition and cancer stem cells. OncoTargets Ther. 2013;6:1261\u20137.","journal-title":"Onco Targets Ther."},{"issue":"8","key":"6925_CR6","doi-asserted-by":"publisher","first-page":"e71309","DOI":"10.1371\/journal.pone.0071309","volume":"8","author":"A Su","year":"2013","unstructured":"Su A, He S, Tian B, et al. MicroRNA-221 mediates the effects of PDGF-BB on migration, proliferation, and the epithelial-mesenchymal transition in pancreatic cancer cells. PLoS ONE. 2013;8(8):e71309.","journal-title":"PLoS One."},{"issue":"7","key":"6925_CR7","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1083\/jcb.200601018","volume":"172","author":"JM Lee","year":"2006","unstructured":"Lee JM, Dedhar S, Kalluri R, Thompson EW. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol. 2006;172(7):973\u201381.","journal-title":"J Cell Biol."},{"issue":"10","key":"6925_CR8","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1002\/bies.1132","volume":"23","author":"P Savagner","year":"2001","unstructured":"Savagner P. Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays. 2001;23(10):912\u201323.","journal-title":"Bioessays."},{"issue":"5","key":"6925_CR9","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139(5):871\u201390.","journal-title":"Cell."},{"issue":"6","key":"6925_CR10","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Investig. 2009;119(6):1420\u20138.","journal-title":"J Clin Invest."},{"issue":"3","key":"6925_CR11","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/BCR.0b013e318240541e","volume":"33","author":"CE Weber","year":"2012","unstructured":"Weber CE, Li NY, Wai PY, Kuo PC. Epithelial-mesenchymal transition, TGF-beta, and osteopontin in wound healing and tissue remodeling after injury. J Burn Care Res. 2012;33(3):311\u20138.","journal-title":"J Burn Care Res."},{"issue":"1","key":"6925_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jdermsci.2010.11.015","volume":"61","author":"M Nakamura","year":"2011","unstructured":"Nakamura M, Tokura Y. Epithelial-mesenchymal transition in the skin. J Dermatol Sci. 2011;61(1):7\u201313.","journal-title":"J Dermatol Sci."},{"issue":"1","key":"6925_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jdermsci.2009.06.009","volume":"56","author":"LG Hudson","year":"2009","unstructured":"Hudson LG, Newkirk KM, Chandler HL, et al. Cutaneous wound reepithelialization is compromised in mice lacking functional Slug (Snai2). J Dermatol Sci. 2009;56(1):19\u201326.","journal-title":"J Dermatol Sci."},{"issue":"3","key":"6925_CR14","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/jcp.20188","volume":"202","author":"P Savagner","year":"2005","unstructured":"Savagner P, Kusewitt DF, Carver EA, et al. Developmental transcription factor slug is required for effective re-epithelialization by adult keratinocytes. J Cell Physiol. 2005;202(3):858\u201366.","journal-title":"J Cell Physiol."},{"issue":"6","key":"6925_CR15","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nrc822","volume":"2","author":"JP Thiery","year":"2002","unstructured":"Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002;2(6):442\u201354.","journal-title":"Nat Rev Cancer."},{"issue":"6","key":"6925_CR16","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.devcel.2008.05.009","volume":"14","author":"J Yang","year":"2008","unstructured":"Yang J, Weinberg RA. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell. 2008;14(6):818\u201329.","journal-title":"Dev Cell."},{"issue":"5","key":"6925_CR17","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.surg.2013.05.004","volume":"154","author":"S Yamada","year":"2013","unstructured":"Yamada S, Fuchs BC, Fujii T, et al. Epithelial-to-mesenchymal transition predicts prognosis of pancreatic cancer. Surgery. 2013;154(5):946\u201354.","journal-title":"Surgery."},{"issue":"2","key":"6925_CR18","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.canlet.2006.09.007","volume":"249","author":"F Schonleben","year":"2007","unstructured":"Schonleben F, Qiu W, Bruckman KC, et al. BRAF and KRAS gene mutations in intraductal papillary mucinous neoplasm\/carcinoma (IPMN\/IPMC) of the pancreas. Cancer Lett. 2007;249(2):242\u20138.","journal-title":"Cancer Lett."},{"issue":"1","key":"6925_CR19","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s005340200007","volume":"9","author":"K Wada","year":"2002","unstructured":"Wada K. p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas. J Hepatobiliary Pancreat Surg. 2002;9(1):76\u201385.","journal-title":"J Hepatobiliary Pancreat Surg"},{"issue":"23","key":"6925_CR20","doi-asserted-by":"publisher","first-page":"5681","DOI":"10.1242\/dev.00808","volume":"130","author":"M Cheung","year":"2003","unstructured":"Cheung M, Briscoe J. Neural crest development is regulated by the transcription factor Sox9. Development. 2003;130(23):5681\u201393.","journal-title":"Development."},{"issue":"6506","key":"6925_CR21","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/372525a0","volume":"372","author":"JW Foster","year":"1994","unstructured":"Foster JW, Dominguez-Steglich MA, Guioli S, et al. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature. 1994;372(6506):525\u201330.","journal-title":"Nature."},{"issue":"10","key":"6925_CR22","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1136\/jmg.2009.068361","volume":"46","author":"CT Gordon","year":"2009","unstructured":"Gordon CT, Tan TY, Benko S, et al. Long-range regulation at the SOX9 locus in development and disease. J Med Genet. 2009;46(10):649\u201356.","journal-title":"J Med Genet."},{"issue":"25","key":"6925_CR23","doi-asserted-by":"publisher","first-page":"10500","DOI":"10.1073\/pnas.0704054104","volume":"104","author":"FC Lynn","year":"2007","unstructured":"Lynn FC, Smith SB, Wilson ME, et al. Sox9 coordinates a transcriptional network in pancreatic progenitor cells. Proc Natl Acad Sci U S A. 2007;104(25):10500\u20135.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"6","key":"6925_CR24","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1073\/pnas.0609217104","volume":"104","author":"PA Seymour","year":"2007","unstructured":"Seymour PA, Freude KK, Tran MN, et al. SOX9 is required for maintenance of the pancreatic progenitor cell pool. Proc Natl Acad Sci U S A. 2007;104(6):1865\u201370.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"6925_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1258\/ebm.2010.010086","volume":"236","author":"G Chakravarty","year":"2011","unstructured":"Chakravarty G, Moroz K, Makridakis NM, et al. Prognostic significance of cytoplasmic SOX9 in invasive ductal carcinoma and metastatic breast cancer. Exp Biol Med (Maywood). 2011;236(2):145\u201355.","journal-title":"Exp Biol Med (Maywood)."},{"issue":"11","key":"6925_CR26","doi-asserted-by":"publisher","first-page":"4258","DOI":"10.1158\/0008-5472.CAN-07-5805","volume":"68","author":"C Darido","year":"2008","unstructured":"Darido C, Buchert M, Pannequin J, et al. Defective claudin-7 regulation by Tcf-4 and Sox-9 disrupts the polarity and increases the tumorigenicity of colorectal cancer cells. Cancer Res. 2008;68(11):4258\u201368.","journal-title":"Cancer Res."},{"issue":"56","key":"6925_CR27","doi-asserted-by":"publisher","first-page":"7131","DOI":"10.1038\/onc.2008.331","volume":"27","author":"H Zalzali","year":"2008","unstructured":"Zalzali H, Naudin C, Bastide P, et al. CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium. Oncogene. 2008;27(56):7131\u20138.","journal-title":"Oncogene."},{"issue":"11","key":"6925_CR28","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1007\/s00535-011-0443-5","volume":"46","author":"M Sashikawa Kimura","year":"2011","unstructured":"Sashikawa Kimura M, Mutoh H, Sugano K. SOX9 is expressed in normal stomach, intestinal metaplasia, and gastric carcinoma in humans. J Gastroenterol. 2011;46(11):1292\u20139.","journal-title":"J Gastroenterol."},{"issue":"17","key":"6925_CR29","doi-asserted-by":"publisher","first-page":"4363","DOI":"10.1158\/1078-0432.CCR-10-0138","volume":"16","author":"SS Jiang","year":"2010","unstructured":"Jiang SS, Fang WT, Hou YH, et al. Upregulation of SOX9 in lung adenocarcinoma and its involvement in the regulation of cell growth and tumorigenicity. Clin Cancer Res. 2010;16(17):4363\u201373.","journal-title":"Clin Cancer Res."},{"issue":"6","key":"6925_CR30","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1158\/0008-5472.CAN-07-5915","volume":"68","author":"H Wang","year":"2008","unstructured":"Wang H, Leav I, Ibaragi S, et al. SOX9 is expressed in human fetal prostate epithelium and enhances prostate cancer invasion. Cancer Res. 2008;68(6):1625\u201330.","journal-title":"Cancer Res."},{"issue":"6","key":"6925_CR31","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.ccr.2012.10.025","volume":"22","author":"JL Kopp","year":"2012","unstructured":"Kopp JL, von Figura G, Mayes E, et al. Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma. Cancer Cell. 2012;22(6):737\u201350.","journal-title":"Cancer Cell."},{"issue":"3","key":"6925_CR32","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.humpath.2013.10.008","volume":"45","author":"S Shroff","year":"2014","unstructured":"Shroff S, Rashid A, Wang H, et al. SOX9: a useful marker for pancreatic ductal lineage of pancreatic neoplasms. Hum Pathol. 2014;45(3):456\u201363.","journal-title":"Hum Pathol."},{"issue":"1","key":"6925_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/MPA.0b013e3182a70b2f","volume":"43","author":"F Meng","year":"2014","unstructured":"Meng F, Takaori K, Ito T, et al. Expression of SOX9 in intraductal papillary mucinous neoplasms of the pancreas. Pancreas. 2014;43(1):7\u201314.","journal-title":"Pancreas."},{"issue":"3","key":"6925_CR34","first-page":"151","volume":"2","author":"JJ Pan","year":"2011","unstructured":"Pan JJ, Yang MH. The role of epithelial-mesenchymal transition in pancreatic cancer. J Gastrointest Oncol. 2011;2(3):151\u20136.","journal-title":"J Gastrointest Oncol."},{"issue":"1","key":"6925_CR35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/ng.722","volume":"43","author":"K Furuyama","year":"2011","unstructured":"Furuyama K, Kawaguchi Y, Akiyama H, et al. Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nat Genet. 2011;43(1):34\u201341.","journal-title":"Nat Genet."},{"issue":"3","key":"6925_CR36","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/MPA.0b013e318269d281","volume":"42","author":"T Tanaka","year":"2013","unstructured":"Tanaka T, Kuroki T, Adachi T, et al. Evaluation of SOX9 expression in pancreatic ductal adenocarcinoma and intraductal papillary mucinous neoplasm. Pancreas. 2013;42(3):488\u201393.","journal-title":"Pancreas."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-018-6925-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-6925-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-6925-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T00:13:40Z","timestamp":1571876020000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-018-6925-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,24]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["6925"],"URL":"https:\/\/doi.org\/10.1245\/s10434-018-6925-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,24]]},"assertion":[{"value":"18 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors do not have any disclosures to report.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}